A published report says Johnson & Johnson is creating a new position to ensure companywide quality production and compliance.

The move comes as the health care giant's once-stellar reputation for quality is being tarnished by repeated recalls of nonprescription medicines.

The Wall Street Journal is reporting that J&J veteran executive Ajit Shetty will oversee the company's medical device and consumer groups. Chief quality officers for each business will report to him.

The maker of Band-Aids and Tylenol cut its 2010 profit forecast in June due to costs associated with the recalls and the long-term shut down of a factory.